Rab4 interacts with the human P-glycoprotein and modulates its surface expression in multidrug resistant K562 cells

International Journal of Cancer

Volumn 128, Issue 1, 2011, Pages 192-205

  Ferrándiz Huertas, Clotilde ^a   Fernández Carvajal, Asia ^a   Ferrer Montiel, Antonio ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

ABC transporters; Cancer; Chemotherapy; Multidrug resistance; Protein trafficking; Rab proteins

Indexed keywords

DAUNORUBICIN; GLYCOPROTEIN P; GREEN FLUORESCENT PROTEIN; GUANOSINE TRIPHOSPHATASE; RAB PROTEIN;

ARTICLE; CELL MEMBRANE; CELL MIGRATION; CELL STRAIN HEK293; CELL STRAIN K 562; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; DRUG ACCUMULATION; DRUG UPTAKE; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTRACELLULAR SPACE; MODULATION; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION;

AMINO ACID SEQUENCE; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL MEMBRANE; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENDOSOMES; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; K562 CELLS; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEIN; PROTEIN BINDING; RAB GTP-BINDING PROTEINS; RAB4 GTP-BINDING PROTEINS; RNA INTERFERENCE; SEQUENCE HOMOLOGY, AMINO ACID; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 78349232335     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25310     Document Type: Article

References (51)

1. Bellamy WT,. P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol 1996; 36: 161 83.
2. Ling V,. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 1997; 40 Suppl: S3 S8.
3. Borst P, Elferink RO,. Mammalian ABC transporters in health and disease. Annu Rev Biochem 2002; 71: 537 92.
4. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC,. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987; 84: 7735 8.
5. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR,. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989; 86: 695 8.
6. Tanaka Y, Abe Y, Tsugu A, Takamiya Y, Akatsuka A, Tsuruo T, Yamazaki H, Ueyama Y, Sato O, Tamaoki N,. Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas. Virchows Arch 1994; 425: 133 8.
7. Schinkel AH,. The physiological function of drug-transporting P-glycoproteins. Semin Cancer Biol 1997; 8: 161 70.
8. Sharom FJ,. The P-glycoprotein efflux pump: how does it transport drugs? J Membr Biol 1997; 160: 161 75.
9. Tan B, Piwnica-Worms D, Ratner L,. Multidrug resistance transporters and modulation. Curr Opin Oncol 2000; 12: 450 8.
10. Klohs WD, Steinkampf RW, Havlick MJ, Jackson RC,. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists. Cancer Res 1986; 46: 4352 6.
11. Perez-Victorias FJ, Conseil G, Munoz-Martinez F, Perez-Victoria JM, Dayan G, Marsaud V, Castanys S, Gamarro F, Renoir JM, Di Pietro A,. RU49953: a non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance. Cell Mol Life Sci 2003; 60: 526 35.
12. Slater LM, Sweet P, Stupecky M, Gupta S,. Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. J Clin Invest 1986; 77: 1405 8.
13. Tang R, Faussat AM, Perrot JY, Marjanovic Z, Cohen S, Storme T, Morjani H, Legrand O, Marie JP,. Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML). BMC Cancer 2008; 8: 51.
14. Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y,. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res 1984; 44: 4303 7.
15. Masip I, Cortes N, Abad MJ, Guardiola M, Perez-Paya E, Ferragut J, Ferrer-Montiel A, Messeguer A,. Design and synthesis of an optimized positional scanning library of peptoids: identification of novel multidrug resistance reversal agents. Bioorg Med Chem 2005; 13: 1923 9.
16. Masip I, Ferrandiz-Huertas C, Garcia-Martinez C, Ferragut JA, Ferrer-Montiel A, Messeguer A,. Synthesis of a library of 3-oxopiperazinium and perhydro-3-oxo-1,4-diazepinium derivatives and identification of bioactive compounds. J Comb Chem 2004; 6: 135 41.
17. Robert J, Jarry C,. Multidrug resistance reversal agents. J Med Chem 2003; 46: 4805 17.
18. Rao PS, Mallya KB, Srivenugopal KS, Balaji KC, Rao US,. RNF2 interacts with the linker region of the human P-glycoprotein. Int J Oncol 2006; 29: 1413 19.
19. Georges E,. The P-glycoprotein (ABCB1) linker domain encodes high-affinity binding sequences to α- and β-tubulins. Biochemistry 2007; 46: 7337 42.
20. Barakat S, Demeule M, Pilorget A, Regina A, Gingras D, Baggetto LG, Beliveau R,. Modulation of p-glycoprotein function by caveolin-1 phosphorylation. J Neurochem 2007; 101: 1 8.
21. Jodoin J, Demeule M, Fenart L, Cecchelli R, Farmer S, Linton KJ, Higgins CF, Beliveau R,. P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins. J Neurochem 2003; 87: 1010 23.
22. Cai C, Chen J,. Overexpression of caveolin-1 induces alteration of multidrug resistance in Hs578T breast adenocarcinoma cells. Int J Cancer 2004; 111: 522 9.
23. Rao PS, Bickel U, Srivenugopal KS, Rao US,. Bap29varP, a variant of Bap29, influences the cell surface expression of the human P-glycoprotein. Int J Oncol 2008; 32: 135 44.
24. Fu D, van Dam EM, Brymora A, Duggin IG, Robinson PJ, Roufogalis BD,. The small GTPases Rab5 and RalA regulate intracellular traffic of P-glycoprotein. Biochim Biophys Acta 2007; 1773: 1062 72.
25. Fu D, Roufogalis BD,. Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation. Am J Physiol Cell Physiol 2007; 292: C1543 C1552.
26. Kim H, Barroso M, Samanta R, Greenberger L, Sztul E,. Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cells. Am J Physiol 1997; 273: C687 C702.
27. Hu W, Howard M, Lukacs GL,. Multiple endocytic signals in the C-terminal tail of the cystic fibrosis transmembrane conductance regulator. Biochem J 2001; 354: 561 72.
28. van der Sluijs P, Hull M, Webster P, Male P, Goud B, Mellman I,. The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway. Cell 1992; 70: 729 40.
29. Proikas-Cezanne T, Gaugel A, Frickey T, Nordheim A,. Rab14 is part of the early endosomal clathrin-coated TGN microdomain. FEBS Lett 2006; 580: 5241 6.
30. Mohrmann K, Leijendekker R, Gerez L, van der Sluijs P,. rab4 regulates transport to the apical plasma membrane in Madin-Darby canine kidney cells. J Biol Chem 2002; 277: 10474 81.
31. Junutula JR, De Maziere AM, Peden AA, Ervin KE, Advani RJ, van Dijk SM, Klumperman J, Scheller RH,. Rab14 is involved in membrane trafficking between the Golgi complex and endosomes. Mol Biol Cell 2004; 15: 2218 29.
32. Daro E, van der Sluijs P, Galli T, Mellman I,. Rab4 and cellubrevin define different early endosome populations on the pathway of transferrin receptor recycling. Proc Natl Acad Sci USA 1996; 93: 9559 64.
33. Morenilla-Palao C, Planells-Cases R, Garcia-Sanz N, Ferrer-Montiel A,. Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J Biol Chem 2004; 279: 25665 72.
34. Garcia-Sanz N, Fernandez-Carvajal A, Morenilla-Palao C, Planells-Cases R, Fajardo-Sanchez E, Fernandez-Ballester G, Ferrer-Montiel A,. Identification of a tetramerization domain in the C terminus of the vanilloid receptor. J Neurosci 2004; 24: 5307 14.
35. Merkerova M, Klamova H, Brdicka R, Bruchova H,. Targeting of gene expression by siRNA in CML primary cells. Mol Biol Rep 2007; 34: 27 33.
36. Caprini M, Gomis A, Cabedo H, Planells-Cases R, Belmonte C, Viana F, Ferrer-Montiel A,. GAP43 stimulates inositol trisphosphate-mediated calcium release in response to hypotonicity. EMBO J 2003; 22: 3004 14.
37. Huet S, Marie JP, Gualde N, Robert J,. Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French Drug Resistance Network. Cytometry 1998; 34: 248 56.
38. Bock JB, Matern HT, Peden AA, Scheller RH,. A genomic perspective on membrane compartment organization. Nature 2001; 409: 839 41.
39. Zerial M, McBride H,. Rab proteins as membrane organizers. Nat Rev Mol Cell Biol 2001; 2: 107 17.
40. Sonnichsen B, de Renzis S, Nielsen E, Rietdorf J, Zerial M,. Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11. J Cell Biol 2000; 149: 901 14.
41. Soto F, Planells-Cases R, Canaves JM, Ferrer-Montiel AV, Aleu J, Gamarro F, Castanys S, Gonzalez-Ros JM, Ferragut JA,. Possible coexistence of two independent mechanisms contributing to anthracycline resistance in leukaemia P388 cells. Eur J Cancer 1993; 29A: 2144 50.
42. Gottesman MM, Pastan I, Ambudkar SV,. P-glycoprotein and multidrug resistance. Curr Opin Genet Dev 1996; 6: 610 17.
43. Juliano RL, Ling V,. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152 62.
44. Ueda K, Cardarelli C, Gottesman MM, Pastan I,. Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 1987; 84: 3004 8.
45. Demeule M, Jodoin J, Gingras D, Beliveau R,. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Lett 2000; 466: 219 24.
46. Ronaldson PT, Bendayan M, Gingras D, Piquette-Miller M, Bendayan R,. Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures. J Neurochem 2004; 89: 788 800.
47. Cormont M, Bortoluzzi MN, Gautier N, Mari M, van Obberghen E, Marchand-Brustel Y,. Potential role of Rab4 in the regulation of subcellular localization of Glut4 in adipocytes. Mol Cell Biol 1996; 16: 6879 86.
48. Filipeanu CM, Zhou F, Lam ML, Kerut KE, Claycomb WC, Wu G,. Enhancement of the recycling and activation of β-adrenergic receptor by Rab4 GTPase in cardiac myocytes. J Biol Chem 2006; 281: 11097 103.
49. Odley A, Hahn HS, Lynch RA, Marreez Y, Osinska H, Robbins J, Dorn GW,. Regulation of cardiac contractility by Rab4-modulated β2-adrenergic receptor recycling. Proc Natl Acad Sci USA 2004; 101: 7082 7.
50. Saxena SK, Kaur S, George C,. Rab4GTPase modulates CFTR function by impairing channel expression at plasma membrane. Biochem Biophys Res Commun 2006; 341: 184 91.
51. Saxena SK, Singh M, Shibata H, Kaur S, George C,. Rab4 GTP/GDP modulates amiloride-sensitive sodium channel (ENaC) function in colonic epithelia. Biochem Biophys Res Commun 2006; 340: 726 33.